Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases
NCT06529913 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280
Last updated 2026-02-24
Summary
The goal of this clinical trial is to collect environmental, bio-humoral, and clinical data derived from patients with allergic contact dermatitis (ACD) and systemic metal allergic syndromes related to the exposure to heavy metals, nanoparticles, and emergent contaminants and from healthy subjects.
The main question it aims to answer is: are environmental, bio-humoral, and clinical data derived from patients with ACD and systemic metal allergic syndromes, related to the exposure to heavy metals, nanoparticles, and emergent contaminants, different from ones obtained by healthy subjects? Researchers will compare serum and urine concentration of heavy metals and nanoparticles, patch test to metals, within-breath analysis of oscillometry parameters, serum zonulin, and serum levels of protein oxidation products among patients with systemic allergic syndrome (1st study group), patients with ACD (2nd study group) and healthy subjects (3rd study group).
Participants will undergo:
* measurement of exposure to heavy metals and nanoparticles including nickel, cobalt, chromium, palladium, molybdenum, aluminium, and copper, through serum and urine measurement of concentration.
* Patch test to before mentioned metals.
* Within-breath analysis of oscillometry parameters.
* Measurement of serum zonulin (related to gastro-intestinal exposure).
* Measurement of serum levels of protein oxidation products (as markers of systemic oxidative stress).
Conditions
- Allergic Contact Dermatitis
- Metal Allergy
- Food Allergy
- Nickel Sensitivity
- Nickel; Eczema
- Aluminum Allergy
- Chromium; Eczema
- Functional Gastrointestinal Disorders
- Respiratory Injury
- Pollution; Exposure
- Pollution Related Respiratory Disorder
- Environmental Exposure
- Environment Related Disease
- Environmental Illness
- Oxidative Stress
- Risk Reduction
Interventions
- DIAGNOSTIC_TEST
-
Collection of environmental, biological, and clinical data
All enrolled patients/healthy volunteers will undergo: * measurement of serum and urine concentration of metals (nickel, cobalt, chromium, palladium, molybdenum, aluminium, and copper). * Patch test to metals. * Within-breath analysis of oscillometry parameters. * Measurement of serum zonulin. * Measurement of serum levels of protein oxidation products.
Sponsors & Collaborators
-
University of Bologna
collaborator OTHER -
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Angela Rizzi, MD, PhD · Fondazione Policlinico Universitario A. Gemelli, IRCCS
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-01-13
- Primary Completion
- 2026-09-30
- Completion
- 2026-12-31
Countries
- Italy
Study Locations
More Related Trials
-
A Prospective Study to Investigate Contact Sensitization Using Classic and Machine Learning Techniques
NCT05991674 ·Status: UNKNOWN
-
Molecular Diagnosis of Allergic Contact Dermatitis (SMECA).
NCT06124781 ·Status: RECRUITING ·Phase: NA
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing
NCT00104390 ·Status: COMPLETED ·Phase: PHASE1
-
Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.
NCT03166241 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
NCT00640250 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers
NCT03625219 ·Status: COMPLETED ·Phase: NA
-
Effects of Electroacupuncture to Relieve Itching Degree in Patients With Chronic Atopic Eczema
NCT05529836 ·Status: UNKNOWN ·Phase: NA
-
Skin Test Study of BM32
NCT01350635 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Metal Panel Allergen Patch Test Study
NCT04500834 ·Status: UNKNOWN ·Phase: PHASE3
-
Physiological Study to Determine the Allergic Skin Activity After Different Skin Preparation
NCT01628484 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study to Standardize Allergen Extracts: Determination of Biological Activity in HEP Units
NCT01412528 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
NCT00640614 ·Status: COMPLETED ·Phase: PHASE3
-
Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
NCT00196430 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests
NCT01816542 ·Status: UNKNOWN ·Phase: NA
-
Immune Reactions in Contact Dermatitis Affected Skin
NCT01546298 ·Status: COMPLETED
-
Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis
NCT00868842 ·Status: COMPLETED
-
Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)
NCT02163122 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allergen Exposure
NCT02074930 ·Status: COMPLETED ·Phase: NA
-
Penicillin Allergy Testing and Resensitization Rate
NCT03942731 ·Status: COMPLETED
-
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
NCT06130462 ·Status: COMPLETED ·Phase: NA
-
Allergic Disease Onset Prevention Study
NCT05003804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assess Itch Behavior in Nickel Sulphate Sensitized Volunteers
NCT01529320 ·Status: COMPLETED ·Phase: PHASE1
-
Systemic Nickel Allergy Syndrome: Intervention Study for the Assessment of the Dietary Indications
NCT04432896 ·Status: COMPLETED ·Phase: NA
-
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
NCT02680405 ·Status: UNKNOWN